Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Biovica International AB (publ)
  6. News
  7. Summary
    BIOVIC B   SE0008613731

BIOVICA INTERNATIONAL AB (PUBL)

(BIOVIC B)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Biovica International AB : – Annual report for the financial year 2020/2021 published

06/30/2021 | 02:01am EDT

Annual report for the financial year 2020/2021 for Biovica International AB is published today on our website

© Modular Finance, source Nordic Press Releases

All news about BIOVICA INTERNATIONAL AB (PUBL)
09/15BIOVICA INTERNATIONAL : DiviTum®TKa results from SWOG study published in Clinica..
AQ
09/14BIOVICA INTERNATIONAL : Promising DiviTumTKa results from BioItaLEE study presen..
AQ
09/13BIOVICA INTERNATIONA : Biovica International
AQ
09/13BIOVICA INTERNATIONAL : provides update on FDA application process
AQ
08/31BIOVICA INTERNATIONAL : Announcement from Biovica International's annual general..
AQ
08/31BIOVICA INTERNATIONAL : DiviTum®TKa approaching FDA approval
AQ
08/27BIOVICA INTERNATIONAL : CEO's presentation ahead of the 2021 Annual General Meet..
AQ
08/10BIOVICA INTERNATIONAL : strengthens management team
AQ
08/10Biovica Appoints Warren Cresswell as President Americas
CI
07/30BIOVICA INTERNATIONAL : Notice of annual general meeting in Biovica Internationa..
AQ
More news
Financials
Sales 2022 48,6 M 5,63 M 5,63 M
Net income 2022 -32,6 M -3,77 M -3,77 M
Net cash 2022 252 M 29,2 M 29,2 M
P/E ratio 2022 -54,8x
Yield 2022 -
Capitalization 1 532 M 177 M 177 M
EV / Sales 2022 26,3x
EV / Sales 2023 8,44x
Nbr of Employees 20
Free-Float 41,9%
Chart BIOVICA INTERNATIONAL AB (PUBL)
Duration : Period :
Biovica International AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 55,30 SEK
Average target price 103,00 SEK
Spread / Average Target 86,3%
EPS Revisions
Managers and Directors
Anders Rylander Chief Executive Officer & Director
Cecilia Driving CFO, Head-Human Resource, IR & EVP
Lars Erik Holmqvist Chairman
Mattias Bergqvist Director-Clinical Development
Otti Bengtsson Gref Director-Research & Development
Sector and Competitors